Platform Technology Partners’s Edwards Lifesciences EW Stock Holding History

Platform Technology Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$338K	Buy	3,741 +695	+23%	+$58.2K	0.06%	236
2026 Q1	$244K	Buy	+3,046	New	+$251K	0.05%	273
2025 Q1	–	Sell	-3,090	Closed	-$229K	–	238
2024 Q4	$229K	Sell	3,090 -48	-2%	-$3.36K	0.07%	197
2024 Q3	$207K	Hold	3,138	–	–	0.07%	210
2024 Q2	$290K	Buy	+3,138	New	+$278K	0.1%	166
2023 Q4	$273K	Hold	3,138	–	–	0.11%	168
2023 Q3	$217K	Hold	3,138	–	–	0.1%	170
2023 Q2	$290K	Hold	3,138	–	–	0.14%	151
2023 Q1	$260K	Hold	3,138	–	–	0.13%	157
2022 Q4	$234K	Hold	3,138	–	–	0.12%	162
2022 Q3	$259K	Sell	3,138 -60	-2%	-$5.77K	0.15%	147
2022 Q2	$304K	Buy	3,198 +845	+36%	+$87.5K	0.17%	130
2022 Q1	$277K	Hold	2,353	–	–	0.13%	151
2021 Q4	$305K	Hold	2,353	–	–	0.13%	162
2021 Q3	$266K	Sell	2,353 -875	-27%	-$99.9K	0.12%	179
2021 Q2	$334K	Buy	+3,228	New	+$304K	0.14%	172

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Platform Technology Partners's EW Position: Q2 2026 in Review

Platform Technology Partners increased its Edwards Lifesciences (EW) stake by 23% in Q2 2026, buying an estimated $58.2K and bringing the position to 3,741 shares worth $338K. The position accounts for 0.06% of the portfolio, ranked #236.

Platform Technology Partners first reported a position in EW in Q2 2021 and has held it in 16 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Platform Technology Partners held 3,741 shares of Edwards Lifesciences worth $338K as of Q2 2026.
Platform Technology Partners bought 695 Edwards Lifesciences shares in Q2 2026, an estimated $58.2K.
Edwards Lifesciences made up 0.06% of Platform Technology Partners's portfolio in Q2 2026, its #236 holding.
Platform Technology Partners first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 16 quarters since.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.